Daily Archives: March 12, 2007

Airbus Is Such A Poor Competitor For Boeing That China Steps In

Airbus is not much competition for Boeing (BA). The new Dreamliners and 747-8 are flying off the shelves. Airbus cannot sell a A-380 super-jumbo to save its life. The company’s parent reported poor earnings and said the current year would be cash-flow negative.

But, what would a great company like Boeing be without competition. It could take Airbus some time to get back on its feet. Its new planes seem to be good on paper. It just needs to build them on time.

With Airbus on the ropes, the Chinese are going to step in. They don’t want Boeing to have it too easy. China is already building a mid-sized regional jet, the ARJ-21. The China Aviation Industry Corporation I says that it can begin making large aircraft by 2020. Since the Chinese are expected to buy over 2,000 aircraft between now and 2025, that is pretty bad news.

Even if the Chinese cannot find customers outside their own borders (boarders) the new initiative may make economic sense based on the country’s need for new airplanes.

Since Airbus is the weaker of the two large commercial air frame companies, the news may be worse for it. But, there is no partying at Boeing headquarters tonight.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

Cramer Calls Hansen Medical the Next Intuitive Surgical

On CNBC’s MAD MONEY, Cramer said he is unveiling a medical delivery technology company and will be doing this as part of a new series.  He is reviewing Hansen Medical (HNSN-NASDAQ), but you have to be careful because it is a very small cap stock and you’ll need one of their catheters if you are jumping in after-hours trading and you should wait a couple or few days.  He thinks this could be the next Intuitive Surgical (ISRG).  This is in the non-pharma healthcare sector and will be partially immune to democratic attempts to take away profits from drug companies.  The company makes robotic catheter systems that doctors and nurses don’t have the same issues with in regular catheters.  They are targeting patients with irregular heart beats and there are more than 5 million people with this in the US.  He thinks the product will be approved in the EU first in the first half of this year, and then he thinks it will be approved in the second half of the year here in the US.  Stereotaxis (STXS) is the only competitor and Hansen’s machines are cheaper.  Intuitive Surgical (ISRG) co-founders are the founders of Hansen and those guys have a monster track record with more than a 1,000% return since coming public.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Cramer’s Oil Service & Drilling Picks

On tonight’s MAD MONEY on CNBC, Jim Cramer said the decline in the oil service stocks because it was a nice day is wrong and he said you can’t think that way.  You have to look over the data more than a day and you can’t look at it on its own.  You have to look at the enterprise on the basis of how its customers are doing.  So Cramer decided that the integrated oils are too hard to decide on because of tough comparisons year over year and earnings will be lower.  The only one he will recommend right now is BP Plc (BP-NYSE) out of the huge integrated oils. 

The drillers and service stocks are the only ones he likes in the oil patch right now because this is the only safe and only profitable place to be.  The integrated oils are increasing their cap-ex projections after thinking oil prices would come back down.  Exxon (XOM) said this and he thinks ConocoPhillips (COP) and Chevron (CVX) will have to say they are picking up drilling and cap-ex.  This is pertaining to the DEEP WATER OIL DRILLERS:  He gave 3 picks that are #3 to #5….. Schlumberger (SLB) is the best one under the stars to him; the best rig maker in this is National Oilwell Varco (NOV); GlobalSantaFe (GSF) is one as well for their buyback and looking for deals. 

His two best plays he made after the first break: 

He noted Halliburton (HAL) that is being punished by the media and the public for moving one its headquarters to Dubai.  HAL has been losing business globally to SLB because of the American fallout from an administration.  Its tender offer is something helping the stock, but Cramer wants you to hold on and not sell into the self-tender.  He said if it is treason what they are doing, you can make money off it.

Transocean (RIG) is his favorite play in oil patch.  They are the best in deep water drilling and has the highest day rates.  He thinks that RIG could either be acquired or merged into a larger entity.  You can even wait until Friday to buy the stock because options expiration this Friday may hold the stock down.  He said this should gravitate toward that $75.00 strike on Friday as a result of options.

In a call-in, Cramer said that Exxon (XOM) is being owned for its buyback.  In another call-in Cramer said he likes Canetic Resources Trust (CNE) in the Canadian Oil Trusts.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

S&P 500 Stocks Furthest Below 50-Day Moving Average

From Ticker Sense

Below we provide historical 50-day moving average spread charts of the 10 stocks in the S&P 500 that are trading furthest below their 50-day moving average.  The 50-day spread is simply the percentage above or below the stock’s 50-day moving average and is represented by the blue lines in the charts below.  The red and green horizontal lines represent the high and low extremes of the spread over the time period covered.  We have also included the stock’s current money flows as represented by the dark red lines.  Much more information can be found on our money flow analysis at Birinyi.com and by subscribing to our Mini Institutional service, but in general we are looking for a nice, solid uptrend in the money flow line along with a divergence from the stock’s price.

50day13

50day2

50day3

http://www.tickersense.typepad.com/

Performance of the Sell Side’s Best Idea Lists

From Ticker Sense

This weekend’s issue of Barron’s had an interesting story which recapped the performance of sell-side brokerage firms’ "Best Idea" lists.  As the table below shows, the results were not too flattering.  Overall, the group trailed the performance of the S&P 500 equal-weighted index in each time period covered.

There were some bright spots however.  Smith Barney managed to outperform the benchmark in three out of four periods, while Morgan Keegan outperformed the market in two out of three (There was no data for the five year period).  The best performance though was turned in by Matrix.  While data for the firm was only available for the most recent two periods, the company managed to outperform in both periods by a comfortable margin.

Brokerage_best_idea_lists

http://www.tickersense.typepad.com/

Should Companies Give Quarterly Guidance?

By William Trent, CFA of Stock Market Beat

End quarterly earnings guidance: business group – Mar. 12, 2007

The U.S. Chamber of Commerce called Monday for an end to quarterly earnings guidance by companies, a shake-up at the Securities and Exchange Commission, optional federal charters for insurers, protections for auditors, and retirement savings initiatives.In a laundry list of business community goals, some old and some new, a commission formed by the chamber – the nation’s largest lobbying group for business interests – said the changes were needed because U.S. markets face new challenges.

We have mixed feelings about the whole quarterly guidance game. It does reinforce short-termism, but shareholders are the company owners and presumably are entitled to know what management expects. The problem is when expectations and reality get out of whack, and the disclosures start doing more harm than good. However, we believe this situation is rare and the presumption should be that more disclosure is better until proven otherwise.

As a general rule, we would prefer hard data to management’s (or anyone else’s) expectations. Monthly sales reports, retail product sell-through and other resources offer a better glimpse into what is really happening and would seem less subject to manipulation. We would gladly exchange quarterly EPS guidance for more frequent updates of useful hard data.

http://stockmarketbeat.com/blog1/

STLD: Steel Dynamics Raises Earnings Guidance

By William Trent, CFA of Stock Market Beat

Steel Dynamics (STLD) is just the right size to be one of the companies that qualifies for inclusion on our Small Cap Watch List, Mid Cap Watch List and Large Cap Watch List. Which is good, because it can now benefit all three portfolios.
Steel Dynamics Raises Earnings Guidance for First Quarter: Financial News – Yahoo! Finance

Steel Dynamics, Inc. today announced it is raising its estimate of first quarter 2007 earnings due primarily to higher shipping volumes and somewhat stronger margins than initially projected. The company now expects first-quarter diluted earnings per share to be about 10 percent higher than its preliminary first-quarter estimate of $0.85 to $0.90 per share, revising its estimated range to $0.94 to $0.98 per share. SDI’s preliminary estimate was made January 23, 2007, in the company’s earnings release. By comparison, diluted earnings per share for the first quarter of 2006 was $0.76 and for the fourth quarter of 2006 was $1.03 per share.”

Steel scrap prices are trending much higher in the first quarter than previously forecast,” Busse said. “However, we currently expect to be able to maintain our margins in the second quarter. With continued strong order entry in the second quarter, the preliminary outlook is for a solid quarter. We continue to expect 2007 to be another strong year for SDI, with a higher volume of shipments and good prospects for continued strong margins.”

The consensus estimate for the current quarter was $0.88, smack in the middle of previous guidance.  The consensus for next quarter is $0.96, which implies a slowdown in the year/year earnings growth rate. Judging from the “preliminary outlook for a solid quarter” that number should probably come up as well.

http://www.stockmarketbeat.com/

The 52-Week Low Club

New Century Financial (NEW) Sub-prime lender my fill for Chapter 11. Dropped to $1.65 down from 52-week high of $51.97.

Conseco (CNO) Still taking a pounding for weak numbers in last reported quarter. Dropped to $17.35 down from 52-week high of $25.95.

Beazer Homes (BZH) Following down shares in fellow housing firm Hovnanian (HOV) after it announced poor earnings BZH hits $34.20 down from 52-week high of $69.61.

Accredited Home Lenders (LEND) Caught in the subprime mortgage panic. Drops to $11.35 down from 52-week high of $60.13.

Beacon Power (BCON) Company has done financing that dilutes stock. Renewable energy company stock drops to $.74 down from 52-week high of $2.01

Shuffle Masters (SHFL) Maker of card shufflers downgraded. Stock drops to $19.19 from 52-week high of $40.75.

Clearwire (CLWR) The WiMax firm just went public but can’t have a good day. Down to $19.52 from high of $27.95 just a few days ago.

Douglas A. McIntyre

Texas Instruments Mid-Quarter Update

Texas Instruments’ (TXN-NYSE) mid-quarter update:  TXN expects EPS between $0.29 and $0.33, compared with the previous range of $0.28 to $0.34 on total revenue of between $3.07 billion and $3.22 billion, compared with the prior range of $3.01 billion to $3.28 billion.  Wall Street estimates are $0.31 EPS & $3.15 Billion Revenues for the quarter.

Semiconductor revenue between $3.01 billion and $3.14 billion, compared with the prior range of $2.95 billion to $3.20 billion; Education Technology revenue between $60 million and $80 million, unchanged from the prior range.

Shares fell 1.8% right after the news to $32.00 after closing up 0.4% at $32.59 in regular trading.  Shares closed at $30.90 one-week ago.  We’ll see how this trades in the morning, because this looks largely in-line with previous estimates.  Shares had gotten up to the higher-end of a recent trading range, so it is possible the fast money crowd was hoping for more since analog chip makers liek National Semi (NSM) recently did well on their guidance.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Earnings Preview: Goldman Sachs (GS)

Goldman Sachs (GS-NYSE) reports tomorrow morning on its earnings numbers for the quarter.  Estimates are for 3.5% revenue growth to $10.7 billion and EPS of $4.90, which compares to $5.09/share in the same quarter last year.  Now by all accounts, the first quarter results from last year were a blowout, as actual results came in 54% above the $3.29 estimates.

But tomorrow we will see the beginning of a hard year for Goldman in terms of comparisons, as the financial sector as a whole is running on very high earnings figures.  Goldman’s earnings estimates for the current year are running 2-3% less than ’06 levels, compared to expectations for moderate earnings growth across the sector of about 6%.

The recently-tepid IPO & secondary markets may not bode well for Goldman’s investment banking business where they remain a massive player.  While Goldman has fairly diversified revenue streams from its increasingly global trading business, it’s the investment banking unit that can drive earnings.  We now hear about all of the sub-prime mortgage activities that Wall Street brokerage firms have exposure to, and that talk won’t stop.  Goldman Sachs has exposure to the area, although it has been a moneymaker for them.  We’ll find out tomorrow if that has changed.

GS stock has certainly been a market superstar in the past year, up over 80% since March 2006.  But try as they might to fight it, the company is highly sensitive to the overall level of economic growth and liquidity within the markets.  If either of these two variables start to erode, a lot of earnings at Goldman will be at risk, and the 10x forward multiple on the stock won’t look quite as safe as before.

Most analysts know, however, that Goldman can manage to do a pretty good job of maintaining decent margins in a downturn.   A weakening IPO market can trickle-down to many levels for Goldman Sachs, particularly since is raised an estimated $24 billion in private equity over the past 18 months.  A slow IPO market will limit the "going private" transactions from having an exit other than selling to other buyers rather than to the public.

Jim Cramer has been a steady supporter of Goldman Sachs, and this was his #2 VALUE PICK FOR 2007 just two months ago.  On January 3 when he made the call, shares were at $200.38 and closed up as high as $220.94 in February.  The market slide has taken this back down just under $200.00 this week.  The short sellers decreased their 8.9 million shares in January to 7.02 million shares in February.  As of today, Goldman Sachs has an $83 Billion market cap.  Here is Cramer’s playbook for trading the brokerage firm stocks this week, and he wasn’t his usual bullish self until after the fact.

As a reminder, Wall Street investors have become used to these names beating estimates followed by a sell-the-news mentality if the numbers weren’t a blowout or if they are hard to maintain.  At around $200.00, one has to wonder if the company will try the stock-split feather in their hat to try to drive interest and stock prices.  We’ll keep an eye on the stock heading into earnings along with its peers Lehman Brothers (LEH) and Bear Stearns (BSC), who report later in the week.

Written by Ryan Barnes,
edited by Jon Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Cramer Changes His Mind

On today’s STOP TRADING segment on CNBC, Jim Cramer changed his mind about a stock.  Morgans Hotels (MHGC) has gone up after Cramer thought it wouldn’t.  The CIBC analyst on the show that came on said their target on this one was $27.00.  He thinks the Hard Rock deal may help but the other deals that it has under contract and in negotiations with will drive the company. 

Cramer then said he was looking at Melco PBL Entertainment (MPEL) and said the exposure to Macau on other casinos may come into play against the names.  Cramer said he’s done on Las Vegas Sands (LVS).

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Schering’s Buy of Organon Should be a Win-Win for SGP, Akzo Nobel

Schering-Plough made a move that looks to shore up their pharmaceutical business with one broad stroke, agreeing to acquire Dutch firm Akzo Nobel’s (ADR; AKZOY) Organon BioSciences drug segment for roughly 11b euro, or $14.4 billion USD based on current rates. 

News on the deal sent Akzo’s shares skyrocketing (today up 15% to $70 and change), as the company planned on floating Organon business as an IPO later this month, but expectations were only for a value of $11-12 billion on the stand-alone entity, 22% less than Schering’s offer. 

Even with the premium factored in, Schering seems to have gotten a solid business at a fair price of just under 3x sales (based on 2006 revenue).  Industry average multiples for big pharma are currently in the range of 3.3 – 3.6x sales, and we are still in a historical trough in terms of valuations across the sector.  There are broad-based reasons for this, but on the whole the deal seems like a win-win for both companies.  Akzo doesn’t have to float a new drug stock at a time when the IPO markets are weakening and pharma is generally out of favor.  Schering, meanwhile, shores up their potentially disastrous pipeline issues, picking up 5 drugs in Phase III testing. 

If Schering hadn’t made a move soon to beef up their pipeline, their existing debt would have come under pressure in the next year or two as earnings visibility faded away.  By diversifying their product mix away from risky cholesterol drugs (who doesn’t have a cholesterol drug on the market these days?), Schering can probably sustain investment-grade ratings for the new debt that will have to be added to finance the deal.

The exact details of the financing are not yet known, as to how much debt will be used versus equity and cash.  We do know that as of 12/31/06, Schering’s current account surplus was a little over $6 billion.  We also know that the company is only forecasting an increase of $.10/share to net income during the first year Organon’s results are included.  Based on Organon’s operating profits for 2006, it looks as though Schering will be issuing between 400-500m shares to finance the bulk of the deal, or roughly $8 billion, and will add about $2 b in long-term debt to fill in the remainder. 

We discussed the break-up value of Schering-Plough in depth back on Februrary 1st (http://www.247wallst.com/2007/02/247_wall_st_200.html), and noticed that the $25 price the stock was then trading was an 18% discount to our assessment of the sum of its parts.  Today SGP stock is basically flat on the acquisition news, trading down 10 cents at $23.75, having trended down slightly since our break-up value piece ran.  In our break-up analysis we assessed the pharma business of Schering at exactly 3x sales, so considering the improved pipeline prospects at Organon, it definitely appears that Schering didn’t “buy up” for this deal, and has made an additive purchase. 

Ryan Barnes

March 12, 2007

RadioShack Cut to Junk at Moody’s

Moody’s has downgraded the Debt Rating of RadioShck from Baa3 to Ba1 and taken its short-term rating to "NOT PRIME" from a "PRIME3" rating.  Debt rating downgrades do not often impact equity holders per se, but this one will drive borrowing costs higher now that the electronics retailer is considered "junk status" by Moody’s.  That bars many corporate bond managers from being able to own the bonds.  The downgrade is reflecting the company’s inability to overcome recent sales and operating performance measurements.

Back on February 28 one of our contributors, Chad Brand of Peridot, wrote that the turnaround in the name was underway.  This is interesting that Moody’s would take this action now since turnaround-CEO Julian Day has taken the stock from under $15.00 to more than $26.00 since last summer.  RSH stock has also been doing well in what has not been a good market for the last two weeks.  Goldman Sachs raised this stock from a Neutral to a Buy on January 30.

When you see these it makes you wonder.  The stock has climbed to new "recent" highs and has come within striking distance of two-year highs.  Moody’s is not on the same wavelength as the equity investors so one must wonder which will end up being wrong.  Either Moody’s is just looking at the stock chart and deciding that the fundamentals won’t be strong enough to propel it further from here after such a large run, or the equity crowd is just ignoring the independent analysis. 

Keep in mind that "bond ratings" are much different than equity ratings and the rationale behind debt rating changes is far different than for the equities.  Equity traders often pay attention to the debt rating agencies because there is often "knowledge envy" and a perceived independence of any conflict of interest more so than from traditional Wall Street analysts. 

RSH shares are still up 1.4% ay $26.35 for the day and this would be another 52-week high for the stock if it closes up here.  This used to trade north of $30.00 5-years ago.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

The Humiliation Of Raymond James

Barron’s rated the research efforts of some of the large national and regional brokerages. "As we do every six months, Barron’s rates the stock-picking abilities of brokers that issue focus lists, or rosters of their best ideas."

The list covers research calls from firms as diverse as Smith Barney, Bear Stearns, Charles Schwab, and Credit Suisse. The surprise winner for both the last six months and the last year is tiny Matrix USA.

At the other end of the list is Raymond James. It ranks last for both the six month and one year periods, actually showing negative returns. The S&P 500 total return is up for the periods. Raymond James also ranks last for the last three years and last five years.

The results are so bad that it appears that someone at the firm tried to pick the worst investments they could find. Investors have to wonder how the brokerage keeps its customers.

Douglas A. McIntyre

How The UAW Sent The Big Three’s Jobs Overseas

Very few businesses that are inflexible survive. And, the UAW may be called a union, but it is a business. And, for years it did well. The Reuther years. The UAW got its members pay packages, healthcare, and retirement deals that were the envy of the balance of organized labor.

The first writing on the wall that the Big Three could not support huge labor costs indefinitely came in 1973 during the Arab oil embargo. Fuel efficient cars became important, and from that point on were a permanent part of the US auto sales landscape. The Japanese manufacturers had their foothold.

Gas guzzlers got a reprieve as fuel prices dropped and stayed down through much of the 1980s and 1990s, but it was clear to the oil and car companies that cheap gas had seen its day. The demand for oil was too high and the supply of easy-to-drill oil was dropping.

As circumstances continued to benefit the maker of smaller cars, Toyota’s revenue rose from $114.1 billion in 2002 to $186.7 billion in 2006. Over the same period, GM’s revenue went from $186.7 billion to $192.6 billion.

The UAW did not let up in its demands for better wages and benefits. By 2003, the retirement and healthcare burden per vehicle sold in North America was $1,360 for GM and $180 for Toyota.

And, expensive gas returned with a vengeance. As the Japanese gained market share because their cars were viewed as better built, high fuel prices hit the US car makers with a second punch. Between 2000 and mid-2005, 100,000 hourly workers were dropped from the Big Three work force. The job cuts continued into 2006, as Ford (F) and GM (GM) bought out ten of thousands of workers.

Could all of the jobs have been saved? Perhaps not. But, labor cost disadvantages dropped GM and Ford to the brink of insolvency and the UAW has allowed tens of thousand of jobs to be eliminated or moved overseas.

Some level of flexibility on the part of the union would have helped the car companies. The union argument is that concessions would drive up profits, but, if there are no profits, the logic is academic. Making better cars and introducing new models might also have been a by-product of lower labor costs. It is harder to spend money on quality control when there is little money to spend.

The UAW made a huge amount of money for its members for several decades, but it is currently in the process of putting most of them out of jobs.

Blame the management of the car companies for not being better prepared for the environment that helped Toyota? Yes. Blame the UAW as well.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

HealthShares Launches 9 New ETF’s

This morning HealthShares(TM) ETF’s, from XShares Advisors LLC, is launching 9 new ETF’s dedicated to various aspects of healthcare.  This is in addtion to the 5 launched in January, so there are now 14 different HealthShares ETF’s on the market.  Here are the ETF’s by sector:

HealthShares Autoimmune-Inflammation ETF (HHA)
HealthShares Cancer ETF (HHK)
HealthShares Cardiology ETF (HRD)
HealthShares GI/Gender Health ETF (HHU)
HealthShares Metabolic-Endocrine Disorders ETF (HHM)
HealthShares Neuroscience ETF (HHN)
HealthShares Opthamology ETF (HHZ)
HealthShares Respiratory/Pulmonary ETF (HHR)
HealthShares Composite ETF (HHQ)

Each ETF is comprised of 22 to 25 stocks, except the COMPOSITE with 80 stocks, and tracks their own intellectual models from XShares.  Each index is calculated independently by Standard & Poors.  As a reminder, XShares does allow foreign holdings in these to better expand its coverage universe to each ailment in medicine that it covers. 

This just goes to show you, ETF’s can be created very much into niche-oriented investment vehicles down to very specific strategies into sub-sectors of larger sectors.  More information can be found at the www.healthsharesinc.com web site. 

The one issue that has to be taken into consideration as each sector ETF turns into sub-sector ETF’s is the liquidity.  These are still liquid in a bid/ask spread, but traders may shy away from these with larger capital transactions because of the fact that trading volume is very thin and can even see days where no shares trade hands.  If the trading volume can be increased then investors on Main Street will have much more diversified access to invest into Wall Street sub-sectors.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Ask.com Should Surrender To The Competition

Barry Diller and the folks over at IAC Interactive (IACI) should throw in the towel on Ask.com, their search engine, and sell the rights for search across their other sites to Google (GOOG), Microsoft (MSFT) or Yahoo! (YHOO). Recent figures show that Ask only has 3% of the search market and that is down 28% year-over-year based on measurements made in February.

News Corp (NWS) was able to get $900 million from Google as a minimum payment for an exclusive right to provide search functions and search-based ads to MySpace. News Corp’s monthly audience (including MySpace) in January was about 140 million unique visitors worldwide. IACI’s comparable figure was 109 million. One of the large search engines would certainly be willing to put up a huge deposit for that.

Ask.com is dead. At 3% of the market, it can’t ever take a large enough bite to make the property worthwhile. But Diller could get a substantial figure for the search rights across all of his online businesses and he should.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

Global ETF Overbought Oversold

From Ticker Sense

Below we once again look at the global equity market landscape through our overbought/oversold program.  ETFs highlighted in green are currently oversold while EWJ, the ETF representing the Japanese market, is the only one overbought.  Almost all ETFs are trading higher than where they were 5 days ago, indicating some stabilization has taken place.

Globaletf_3

Oboskey_35

http://www.tickersense.typepad.com/

UST: Review of UST’s 10K – Company Looks Solid But Not Cheap

By William Trent, CFA of Stock Market Beat

Large Cap Watch List member UST (UST) is a leading provider of smokeless tobacco products, which it markets under the Copenhagen, Skoal and other brand names. It also produces Washington State wines. We reviewed the company’s recently issued 10K report, and summarize our key findings below.

First, at risk of stating the obvious, the businesses UST are involved in entail a fair amount of legal, social and regulatory risk. Investors must be comfortable that the price they are paying provides adequate compensation for these risks. Over the last five years this has been the case, as tobacco companies gained 140% compared with just a 35% cumulative gain on the S&P 500. However, there is no assurance that can continue, particularly since sales and earnings have been essentially flat for the last three years. A restructuring initiative that the company believes will result in $100 million of cost savings appears largely incorporated into analyst estimates.

Read More »

Yahoo! May Catch a Break

Yahoo! (YHOO) fell sharply Friday because of the news that AT&T (T) is considering either dropping or renegotiating the DSL pact that SBC had with Yahoo.  There was an estimated $230 to $325 million in revenues at risk to Yahoo over this, and this one was deemed to have high margins.  There are two pieces of information that may actually come to the rescue today.

Reuters has a report stating that Yahoo! is in talks with AT&T’s Cingular unit for a mobile search bundling pact.  The news doesn’t mean that the lost business would be entirely made up for, but this would help to offset the potential DSL losses if that occurs. 

The other issue is a note buried in the Goldman Sachs research this morning.  Goldman Sachs has said it previously noted that they could lose $235 million to $320 million in revenues and $170 million to $235 million in EBITDA.  But now it says that Yahoo! would co-own the joint subscribers if the existing contract ended.  In a sense that means that the bleed-off would not be instant, and AT&T would be required to continue paying Yahoo! as long as the subscribers remain in the current status.  So now this implies that the drop in revenues would have to be driven by a decline in subscribers rather than just by a contract termination alone.  If that is the case then it would not be as bad as it appeared on Friday, even if it is still not a net “good” event.

Jon C. Ogg
March 12, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.